Juárez-Salcedo LM - Search Results

1

Adverse events of radioimmunotherapy for non-Hodgkin lymphoma: A systematic review and meta-analysis.

Sharda E, Patel RS, Juárez-Salcedo LM, Dalia S, Hanna CH, Gruhonjic H, Ponnaganti BS, Mhaskar R. Sharda E, et al. Among authors: juarez salcedo lm. Leuk Res. 2021 Sep;108:106615. doi: 10.1016/j.leukres.2021.106615. Epub 2021 May 11. Leuk Res. 2021. PMID: 34052662 Review.

2

Indolent non-Hodgkin lymphoma treatment in the new drugs era.

Juárez-Salcedo LM, Dalia S. Juárez-Salcedo LM, et al. Chin Clin Oncol. 2020 Dec;9(6):81. doi: 10.21037/cco.2020.01.01. Epub 2020 Feb 11. Chin Clin Oncol. 2020. PMID: 32075392 Free article. No abstract available.

3

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

Juárez-Salcedo LM, Sokol L, Chavez JC, Dalia S. Juárez-Salcedo LM, et al. Cancer Control. 2018 Jan-Mar;25(1):1073274818778256. doi: 10.1177/1073274818778256. Cancer Control. 2018. PMID: 29779412 Free PMC article.

4

Venetoclax: evidence to date and clinical potential.

Juárez-Salcedo LM, Desai V, Dalia S. Juárez-Salcedo LM, et al. Drugs Context. 2019 Oct 9;8:212574. doi: 10.7573/dic.212574. eCollection 2019. Drugs Context. 2019. PMID: 31645879 Free PMC article. Review.

5

The role of anti-PD-1 and anti-PD-L1 agents in the treatment of diffuse large B-cell lymphoma: The future is now.

Juárez-Salcedo LM, Sandoval-Sus J, Sokol L, Chavez JC, Dalia S. Juárez-Salcedo LM, et al. Crit Rev Oncol Hematol. 2017 May;113:52-62. doi: 10.1016/j.critrevonc.2017.02.027. Epub 2017 Mar 9. Crit Rev Oncol Hematol. 2017. PMID: 28427522 Review.

6

Use of check-point inhibitors in the treatment of progressive multifocal leukoencephalopathy.

Juárez-Salcedo LM, Dalia S. Juárez-Salcedo LM, et al. Ann Transl Med. 2019 Dec;7(Suppl 8):S297. doi: 10.21037/atm.2019.11.11. Ann Transl Med. 2019. PMID: 32016016 Free PMC article. No abstract available.

7

Use of anti-CD20 therapy in follicular and marginal zone lymphoma: a review of the literature.

Juárez-Salcedo LM, Conde-Royo D, Quiroz-Cervantes K, Dalia S. Juárez-Salcedo LM, et al. Drugs Context. 2020 May 6;9:2019-9-3. doi: 10.7573/dic.2019-9-3. eCollection 2020. Drugs Context. 2020. PMID: 32426017 Free PMC article. Review.

8

Management of adverse effects of new monoclonal antibody treatments in acute lymphoblastic leukemia.

Conde-Royo D, Juárez-Salcedo LM, Dalia S. Conde-Royo D, et al. Among authors: juarez salcedo lm. Drugs Context. 2020 Oct 14;9:2020-7-2. doi: 10.7573/dic.2020-7-2. eCollection 2020. Drugs Context. 2020. PMID: 33110433 Free PMC article. Review.

9

Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.

Juárez-Salcedo LM, Castillo JJ. Juárez-Salcedo LM, et al. Hematol Oncol Clin North Am. 2019 Aug;33(4):639-656. doi: 10.1016/j.hoc.2019.03.004. Epub 2019 Apr 30. Hematol Oncol Clin North Am. 2019. PMID: 31229160 Review.

10

Excellent outcome of hairy cell leukaemia with extensive mesenteric infiltration following cladribine therapy.

Juárez Salcedo LM, Sandoval-Sus J, Zhang L, Klippenstein D, Chavez JC. Juárez Salcedo LM, et al. Br J Haematol. 2016 Sep;174(5):659. doi: 10.1111/bjh.14200. Epub 2016 Jul 8. Br J Haematol. 2016. PMID: 27391097 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page